Barclays’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.2M Buy
351,198
+249,981
+247% +$15.8M 0.01% 773
2025
Q1
$5.36M Sell
101,217
-34,180
-25% -$1.81M ﹤0.01% 1375
2024
Q4
$7.58M Buy
135,397
+29,000
+27% +$1.62M ﹤0.01% 1299
2024
Q3
$5.57M Buy
106,397
+52,766
+98% +$2.76M ﹤0.01% 1452
2024
Q2
$2.2M Sell
53,631
-73,905
-58% -$3.03M ﹤0.01% 1634
2024
Q1
$5.53M Sell
127,536
-123,879
-49% -$5.37M ﹤0.01% 1323
2023
Q4
$11.6M Buy
251,415
+10,154
+4% +$467K ﹤0.01% 980
2023
Q3
$5.53M Buy
241,261
+111,033
+85% +$2.55M ﹤0.01% 1093
2023
Q2
$2.15M Buy
130,228
+43,110
+49% +$711K ﹤0.01% 1703
2023
Q1
$1.55M Sell
87,118
-95,481
-52% -$1.7M ﹤0.01% 1822
2022
Q4
$5.32M Buy
182,599
+18,246
+11% +$531K ﹤0.01% 1076
2022
Q3
$4.03M Buy
164,353
+155,063
+1,669% +$3.8M ﹤0.01% 1219
2022
Q2
$39K Sell
9,290
-11,909
-56% -$50K ﹤0.01% 3832
2022
Q1
$245K Sell
21,199
-32,270
-60% -$373K ﹤0.01% 3188
2021
Q4
$533K Buy
53,469
+18,175
+51% +$181K ﹤0.01% 2503
2021
Q3
$461K Buy
35,294
+16,806
+91% +$220K ﹤0.01% 2637
2021
Q2
$363K Sell
18,488
-55,795
-75% -$1.1M ﹤0.01% 2637
2021
Q1
$1.58M Buy
74,283
+39,527
+114% +$841K ﹤0.01% 2041
2020
Q4
$1.03M Sell
34,756
-62,369
-64% -$1.85M ﹤0.01% 1957
2020
Q3
$2.11M Sell
97,125
-4,726
-5% -$102K ﹤0.01% 1458
2020
Q2
$2.27M Buy
101,851
+8,127
+9% +$181K ﹤0.01% 1395
2020
Q1
$1.43M Sell
93,724
-34,123
-27% -$520K ﹤0.01% 1512
2019
Q4
$2.94M Buy
127,847
+113,881
+815% +$2.61M ﹤0.01% 1621
2019
Q3
$302K Sell
13,966
-4,521
-24% -$97.8K ﹤0.01% 2874
2019
Q2
$406K Sell
18,487
-1,036
-5% -$22.8K ﹤0.01% 2837
2019
Q1
$536K Buy
19,523
+16,197
+487% +$445K ﹤0.01% 2569
2018
Q4
$90K Sell
3,326
-3,301
-50% -$89.3K ﹤0.01% 3005
2018
Q3
$193K Buy
6,627
+5,302
+400% +$154K ﹤0.01% 3092
2018
Q2
$41K Sell
1,325
-2,843
-68% -$88K ﹤0.01% 3351
2018
Q1
$84K Buy
4,168
+2,862
+219% +$57.7K ﹤0.01% 3246
2017
Q4
$38K Buy
+1,306
New +$38K ﹤0.01% 3450